Physician profile
Robert Digeronimo
NPI 1497788426
$16,365.96
in general payments reported to CMS, 2019-2025
7 companies · $79.69 in 2025
The $79.69 reported for 2025 was more than what a typical Neonatal-Perinatal Medicine provider received nationally (typical 2025 total: $77.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $350 · 2021: $78.41 · 2022: $159 · 2023: $3,390 · 2024: $162 · 2025: $79.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,100 · Food and Beverage: $461 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,100.00 |
| Food and Beverage | $461.30 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $10,313.40 | 2019 | |
| Sobi, INC | $3,100.00 | 2023 | |
| Vapotherm INC | $1,833.77 | 2019 | |
| Mallinckrodt Hospital Products INC. | $549.94 | 2020-2025 | Inomax |
| Medtronic, INC. | $420.44 | 2022-2024 | Mc3 Crescent Jugular Dual Lumen Catheter, Nellcor |
| Getinge USA Sales, LLC | $78.41 | 2021 | |
| Chiesi USA, INC. | $70.00 | 2023 | Curosurf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Digeronimo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.